Synaffix Expands Partnership Horizon with Boehringer Ingelheim
January 9, 2025 - 17:10
In a significant move to enhance its portfolio, Synaffix, a leader in antibody-drug conjugate (ADC) technology, has entered into a new licensing agreement with Boehringer Ingelheim. This partnership allows Boehringer to leverage Synaffix's advanced ADC technologies for a specified number of cancer targets, although the exact details regarding the number of targets remain confidential.
This agreement marks a strategic step for Synaffix as it continues to build on its momentum from last year, when it secured several partnerships. Additionally, Synaffix has expanded its collaboration network by forming a technology licensing deal with Mitsubishi Tanabe Pharma in Japan. These developments underscore Synaffix's commitment to advancing cancer treatment options through innovative ADC technologies.
As the landscape of cancer therapeutics evolves, this collaboration with Boehringer Ingelheim is poised to accelerate the development of novel ADC therapies, potentially leading to more effective treatment solutions for patients battling cancer.
MORE NEWS
February 15, 2026 - 04:14
Researchers develop powerful new technology that could transform space missions: 'We're just starting to see some of the results'A breakthrough in solar panel design is paving the way for more ambitious and durable missions beyond Earth`s orbit. Researchers have developed a new generation of radiation-tolerant, thin-film...
February 14, 2026 - 23:05
Align Technology Uses Swiss Oral Health Study To Build Long Term MoatAlign Technology, the maker of Invisalign clear aligners, has announced a major partnership with the University of Bern to launch Switzerland`s first comprehensive national oral health study. The...
February 14, 2026 - 09:50
China top court says drivers responsible despite autonomous technologyIn a landmark ruling, China`s Supreme People`s Court has established that drivers remain legally responsible for vehicles equipped with autonomous driving technology. This definitive legal...
February 13, 2026 - 22:31
OpenAI accuses China's DeepSeek of stealing AI technologyOpenAI, the creator of ChatGPT, has formally accused the Chinese artificial intelligence company DeepSeek of stealing its proprietary AI technology. The allegations, detailed in a recent legal...